- Research article
- Open Access
Utility of certain nucleophilic aromatic substitution reactions for the assay of pregabalin in capsules
© Walash et al 2010
- Received: 8 April 2011
- Accepted: 28 June 2011
- Published: 28 June 2011
Pregabalin (PG) is an anticonvulsant, analgesic and anxiolytic drug. A survey of the literature reveals that all the reported spectrophotometric methods are either don't offer high sensitivity, need tedious extraction procedures, recommend the measurement of absorbance in the near UV region where interference most probably occurs and/or use non specific reagent that don't offer suitable linearity range.
Two new sensitive and simple spectrophotometric methods were developed for determination of pregabalin (PG) in capsules. Method (I) is based on the reaction of PG with 1,2-naphthoquinone-4-sulphonate sodium (NQS), yielding an orange colored product that was measured at 473 nm. Method (II) is based on the reaction of the drug with 2,4-dinitrofluorobenzene (DNFB) producing a yellow product measured at 373 nm. The different experimental parameters affecting the development and stability of the reaction product in methods (I) and (II) were carefully studied and optimized. The absorbance-concentration plots were rectilinear over the concentration ranges of 2-25 and 0.5-8 μg mL-1 for methods (I) and (II) respectively. The lower detection limits (LOD) were 0.15 and 0.13 μg mL-1 and the lower quantitation limits (LOQ) were 0.46 and 0.4 μg mL-1 for methods (I) and (II) respectively.
The developed methods were successfully applied to the analysis of the drug in its commercial capsules. The mean percentage recoveries of PG in its capsule were 99.11 ± 0.98 and 100.11 ± 1.2 (n = 3). Statistical analysis of the results revealed good agreement with those given by the comparison method. Proposals of the reaction pathways were postulated.
- Absorbance Intensity
- Lactose Monohydrate
- Borate Buffer Solution
Pregabalin is not yet the subject of monograph in any pharmacopeia. The literature survey revealed that few analytical methods have been published concerning the analysis of pregabalin in its dosage forms and biological matrices viz, spectrophotometric [3–8], specrtofluorimetric [3, 9–11] and chromatographic [12, 12–26] methods. The chromatographic methods require high cost solvents in addition to elaborate treatment. On the other hand, Specrtofluorimeters are not available in many labs. Regarding spectrophotometric methods for determination of PG, some of them don't offer high sensitivity [5, 7, 8] or need tedious extraction procedures . Meanwhile, some of the spectrophotometric methods recommended the measurement of absorbance in the near UV region where interference most probably occurs [4, 7] or use non specific reagent (Potassium iodide/potassium iodate) that don't offer suitable linearity range . Therefore, our target was to develop rapid, simple, efficient and selective methods for the analysis of PG in pharmaceutical formulations. The proposed methods are based on the reaction of PG through its primary amino group either with 1,2-naphthoquinone-4-sulphonate(NQS) at pH 10.5 or 2,4-dinitrofluorobenzene(DNFB) at pH 9.0 to form colored reaction products peaking at 473 and 373 nm for the two methods, respectively.
The main advantages of the proposed methods are being simple, rapid and not require tedious extraction procedure. Compared to other reported spectrophotometric methods, the proposed methods are either more sensitive or even having comparable sensitivity.
- A Shimadzu UV-Visible 1601 PC Spectrophotometer (Kyoto, Japan) was used for spectrophotometric measurements (P/N 206-67001). The recording range was 0-1.0
- A Consort NV P901 digital pH Meter (Belgium) calibrated with standard buffers was used for checking the pH of the buffer solutions used.
Reagents and materials
Pregabalin pure sample was kindly provided by Pfizer company (Sandwich, UK) with a purity of 100.18% as determined by the comparison method.
Lyrica® capsules batch # 0744019 (labeled to contain 75 mg PG each), ,product of Pfizer company, were obtained from commercial sources in the local Pharmacy.
The 1,2-Naphthoquinone-4-sulphonate sodium (Fluka chemica, USA) solution was freshly prepared as 0.5% (w/v) aqueous solution, for method I.
The 2,4-Dinitrofluorobenzene (Fluka chemica, USA) solution was freshly prepared as 0.3% (v/v) in methanol, for method II.
Methanol, Hydrochloric acid, Borax and Boric acid (BDH, UK).
Borate buffer solutions (0.2 M) were prepared by mixing appropriate volumes of 0. 2 M boric acid with 0.2 M borax and adjusting the pH to 10.5 and 9.0 using pH Meter.
Stock solution of PG was prepared by dissolving 10.0 mg of the drug in 100 mL of distilled water. This solution was further diluted with the same solvent as appropriate to obtain the working concentration range. The stock solution is stable for 7 days when kept in the refrigerator.
General recommended procedures
Procedures for calibration graphs
i. Method I
To a set of 10 mL volumetric flasks, appropriate aliquots of the standard working solution were transferred, to obtain concentrations in the range (2-25 μg mL-1). To each flask 1 ± 0.5 mL of borate buffer solution (pH 10.5) followed by 1.0 mL of NQS solution (0.5%) were added and mixed well. The solutions were heated in thermostatically controlled water bath at 55 ± 5°C for 10 min. The reaction was stopped by cooling under tap water, and solution was completed to the volume with distilled water. The absorbance of the resulting solution was measured at 473 nm against a reagent blank prepared simultaneously. The calibration graph was constructed by plotting the absorbance versus the final concentration of the drug. Alternatively, the corresponding regression equation was derived.
ii. Method II
To a set of 10 mL volumetric flasks, appropriate aliquots of the standard working solution were transferred, to obtain concentrations in the range (0.5-8 μg mL-1). To each flask 1.5 ± 0.5 mL of borate buffer solution (pH 9 ± 0.5) followed by 0.6 ± 0.2 mL of DNFB solution (0.3% v/v) were added and mixed well. The solutions were heated in thermostatically controlled water bath at 70 ± 10°C for 20 min. The reaction was stopped by cooling under tap water, and then 0.2 mL of HCl was added and the solutions were made up to volume with distilled water. The absorbance was measured at 373 nm against a reagent blank. The absorbance was plotted versus the final concentration of the drug to obtain the calibration graph. Alternatively, the corresponding regression equation was derived.
Assay procedure for capsules
The contents of the ten Lyrica® capsules were emptied, weighed and then mixed well. A weighed quantity of the powder equivalent to 40.0 mg PG was transferred into 100 mL conical flask, extracted with 3 X 30 mL of distilled water and filtered if needed into 100 mL volumetric flask and the solution was completed to 100 mL with distilled water to prepare a stock solution of 400 μg mL-1. This solution was further diluted with the same solvent as appropriate to obtain the working concentration range. Aliquots covering the working concentration ranges (8, 15 and 20 μg mL-1 for Method I and 3,4 and 6 μg mL-1 for Method II) were transferred into a series of 10 mL volumetric flasks and the procedures under the two methods were applied. The nominal content of the capsules was determined using the corresponding regression equations or the calibration graphs.
Pregabalin has no specific absorbance since it is aliphatic compounds and devoids of any chromophores or auxchromes which are essential for light absorption. However, a spectrophotometric method was reported for the determination of PG based on the direct measurement of the absorbance at λmax 210 nm (4). In contrast, other repots (7, 10) confirmed that, the drug has no specific absorbance in the UV-region. This renders its spectrophotometric determination a challenging problem. Such problem is highly aggravated when it is necessary to determine the drug especially in pharmaceutical preparations. However, aliphatic nature of PG and presence of a primary amino group which is susceptible to derivitazation with nucleophilic reagents such as NQS or DNFB initiated the present study.
The analytical applications of 2,4-dinitrofluorobenzene (DNFB) for the assay and characterization of specific functional groups such as primary and secondary amines, phenols, thiols and imidazoles have been reported by Connor [30, 31]. In the present work DNFB reacts through a nucleophilic aromatic substitution reaction with the primary aliphatic amino group of PG in aqueous alkaline medium. The reaction between PG and DNFB is very slow at room temperature and required heating to accelerate it. A yellow colored reaction product peaking at 373 nm is produced (Figure 2).
Study of Experimental Parameters
The experimental conditions were established by varying each in turn while keeping all others constant. These variables include; effect of pH and volume of buffer, effect of the concentration of reagents, effect of heating temperature and heating times, effect of diluting solvent and effect of time on stability of the reactions products.
i. Effect of pH and volume of buffer
ii. Effect of the concentration of reagents solutions
iii. Effect of temperature and heating time
iv. Effect of diluting solvent
The effect of diluting solvents on the absorbance intensities of the reactions products was tested using different solvents viz water, methanol, acetone, acetonitrile and dimethylformamide. Using water as diluting solvent gave the highest absorbance values and best peaks shapes. Water was chosen finally as the best diluting solvent for the two methods.
v. Effect of time on stability of the reactions products
Regarding the stability of the produced derivatives, both were found to be stable at room temperature for approximately 2 hour.
Validation of the proposed Methods
The validity of the proposed methods was tested regarding linearity, specificity, accuracy, repeatability and intermediate precision according to ICH Q2(R1) recommendations .
Performance data for the proposed methods
Concentration range (μg mL -1 )
Limit of detection (LOD) (μg mL -1 )
Limit of quantification (LOQ) (μg mL -1 )
Correlation coefficient (r)
Application of the proposed and comparison methods to the determination of PG in pure form
Comparison Method 
Conc. Taken (μg mL-1)
Conc. Found (μg mL-1)
Conc. Taken (μg mL-1)
Conc. found (μg mL-1)
100.16 ± 1.35
100.18 ± 1.05
0.02 (2.26) a
0.51 (2.31) a
1.65 (8.94) a
1.09 (9.01) a
The validity of the methods were proved by statistical evaluation of the regression data, regarding the standard deviation of the residuals (S y/x ), the standard deviation of the intercept (S a ) and standard deviation of the slope (S b ). The results are abridged in
Table 1. The small values of the figures indicate low scattering of the points around the calibration line and high precision.
Limit of quantitation and limit of detection
The limits of quantitation (LOQ) were determined by establishing the lowest concentration that can be measured according to ICH Q2(R1) recommendation  below which the calibration graph is non linear. The results are shown in Table 1. The limits of detection (LOD) were determined by evaluating the lowest concentration of the analyte that can be readily detected. The results are also summarized in Table 1.
Where Sa is the standard deviation of the intercept of regression line, and b is the slope of the regression line.
To test the validity of the proposed methods they were applied to the determination of pure sample of PG over the concentration ranges cited in Table 1. The results obtained were in good agreement with those obtained using the comparison method. Statistical analysis of the result obtained using student t-test and the variance ratio F-test  revealed no significance differences between the proposed and comparison methods regarding the accuracy and precision, respectively (Table 2). The spectrophotometric comparison method  is based on the derivitization of PG with7-chloro-4-nitrobenzofurazon (NBD-Cl) . The absorbance of the reaction product was measured at 460 nm and the concentration was rectilinear over the concentration range 0.5-7.0 μg mL-1.
i. Repeatability (intra-day)
Validation of the proposed methods for the determination of PG pure form
Pregabalin concentration (μg mL-1 )
Pregabalin concentration (μg mL-1 )
ii. Intermediate precision (inter-day)
Application of the proposed and comparison methods to the determination of PG in capsule dosage form
Comparison method 
Conc. taken (μg mL-1)
Conc. taken (μg mL-1)
Lyrica ® Capsules
(75 mg PG/capsule) b
99.11 ± 0.98
100.11 ± 1.20
99.91 ± 0.95
Nominal content of capsule(75 mg)
74.33 ± 0.74
74.08 ± 0.90
Robustness of the method
The robustness of the procedures adopted in the two proposed method was demonstrated by the constancy of the absorbance intensity with the deliberated minor changes in the experimental parameters. For Method I, the changes included the pH of borate buffer solution, 10.5 ± 0.5, the change in the volume of the buffer solution, 1.0 ± 0.5 mL, the change in the volume of NQS (0.5% w/v), 1.0 ± 0.3, the change in the heating temperature, 55 ± 5°C and the change in the heating time, 10 ± 2 min. Meanwhile, for method II these changes included the pH of borate buffer solution, 9.0 ± 0.5, the change in the volume of the buffer solution, 1.5 ± 0.5 mL, the change in the volume of DNFB (0.3% v/v), 0.6 ± 0.2 mL, the change in the heating temperature, 70 ± 10 °C and the change in the heating time, 20 ± 2 min. These minor changes that may take place during the experimental operation didn't affect the absorbance of the reactions products.
The Selectivity of the methods was investigated by observing any interference encountered from the common capsule excipients, such as lactose monohydrate, corn starch and talc. These excipients did not interfere with the proposed methods.
The proposed methods were successfully applied to the determination of the studied drug in its pharmaceutical preparations. The results obtained were statistically compared to those of the comparison method  using Student's t-test for accuracy and the variance ratio F-test for precision respectively (Table 4). The results obtained indicate no significance difference between the proposed methods and the comparison one.
Molar ratio and mechanism of the reaction
For Method II the determination of the stoichiometry of the reaction of PG and DNFB was performed similarly. Plots of log absorbance versus log[DNFB] and log[PG] gave straight lines, the values of their slopes were 0.77 for DNFB and 0.89 for PG (Figure 8). Hence, it is concluded that the reaction proceeds in the ratio of 1:1, confirming that one molecule of the drug condenses with one molecule of DNFB.
The proposed spectrophotometric methods provided sensitive, specific and inexpensive analytical procedures for determination of the non-chromophoric drug PG either per se or in its capsule dosage forms without interference from common excipients. Moreover, the developed methods are less time-consuming and do not require elaborate treatments associated with chromatographic methods. Moreover, the reagents used are nonirritant in contrast for NBD-Cl which cause high irritant effect to the skin these attributes, in addition to the satisfactory sensitivity and reproducibility as well as the convenience and simplicity, make the two proposed methods suitable for routine analysis in quality control laboratories.
- Sweetman S: Martindale: The Complete Drug Reference. 2009, The Pharmaceutical Press: London, 36Google Scholar
- Gajraj NM: Pregabalin: Its Pharmacology and Use in Pain Management. Anesth Analg. 2007, 105: 1805-1815. 10.1213/01.ane.0000287643.13410.5e.View ArticleGoogle Scholar
- Önall A, Sagirli O: Spectrophotometric and spectrofluorimetric methods for the determination of pregabalin in bulk and pharmaceutical preparation. Spectrochim Acta A. 2009, 72: 68-71. 10.1016/j.saa.2008.08.009.View ArticleGoogle Scholar
- Gujral RS, Haque SM, Shanker P: Development and validation of pregabalin in bulk, pharmaceutical formulations and in human urine samples by uv Spectrophotometry. Int J Biomed Sci. 2009, 5: 175-180.Google Scholar
- Önal A: Development and validation of selective spectrophotometric methods for the determination of pregabalin in pharmaceutical preparation. Chin J Chem. 2009, 27: 781-786. 10.1002/cjoc.200990130.View ArticleGoogle Scholar
- Gujral RS, Haque SM, Shanker P: Spectrophotometric Method for the Determination of Pregabalin in Bulk, Pharmaceutical Formulations and in Human Urine Samples. Int J Biomed Sci. 2009, 5: 421-427.Google Scholar
- Navneet K, Karan M, Rishabh N, Kunal N, Arti T, Road F, Kalan G: A sensitive spectrophotometric method for the determination of pregabalin in pure drug and pharmaceutical formulations through benzoylation. IRJP. 2010, 1: 175-180.Google Scholar
- Salem H: Analytical Study for the Charge-Transfer Complexes of Pregabalin. E-J Chem. 2009, 6: 332-340.View ArticleGoogle Scholar
- Walash MI, Belal F, El-Enany N, El-Maghrabey MH: Simple and sensitive spectrofluorimetric method for the determination of pregabalin in capsules through derivatization with fluorescamine. Luminescence. 2010Google Scholar
- Vovk T, Martinc B, Grabnar I: Simple high-throughput method for determination of pregabalin in pharmaceutical dosage forms using a microplate fluorescence reader. Sci Pharm. 2010, 78: 704-10.3797/scipharm.cespt.8.PPAT15.View ArticleGoogle Scholar
- Themelis DG, Tzanavaras PD, Boulimari EA: Generic automated fluorimetric assay for the quality control of gamma aminobutyric acid-analogue anti-epileptic drugs using sequential injection. Anal Lett. 2010, 43: 905-918. 10.1080/00032710903491146.View ArticleGoogle Scholar
- Vermeij TAC, Edelbroek PM: Simultaneous high-performance liquid chromatographic analysis of pregabalin, gabapentin and vigabatrin in human serum by precolumn derivatization with o-phtaldialdehyde and fluorescence detection. J Chromatogr B. 2004, 810: 297-303.View ArticleGoogle Scholar
- Berry D, Millington C: Analysis of Pregabalin at Therapeutic Concentrations in Human Plasma/Serum by Reversed-Phase HPLC. Ther Drug Monit. 2005, 27: 451-456. 10.1097/01.ftd.0000158874.54100.1a.View ArticleGoogle Scholar
- Jadhav AS, Pathare DP, Shingare MS: Validated enantioselective lc method, with precolumn derivatization with marfey's reagent, for analysis of the antiepileptic drug pregabalin in bulk drug samples. Chromatographia. 2007, 65: 253-256. 10.1365/s10337-006-0152-z.View ArticleGoogle Scholar
- Vaidya VV, Yetal SM, Roy SMN, Gomes NA, Joshi SS: LC-MS-MS determination of pregabalin in human plasma. Chromatographia. 2007, 66: 925-928. 10.1365/s10337-007-0430-4.View ArticleGoogle Scholar
- Chen XH, Zhang DL, Deng J, Fu XT: Determination of optical impurity of pregabalin by HPLC with pre-column chiral derivatization. J Chromatogr Sci. 2008, 46: 42-44.View ArticleGoogle Scholar
- Mandal U, Sarkar AK, Gowda KV, Agarwal S, Bose A, Bhaumik U, Ghosh D, Pal TK: Determination of pregabalin in human plasma using LC-MS-MS. Chromatographia. 2008, 67: 237-243. 10.1365/s10337-007-0440-2.View ArticleGoogle Scholar
- Zhang Y, Holliman C, Tang D, Fast D, Michael SJ: Development and validation of a direct enantiomeric separation of pregabalin to support isolated perfused rat kidney studies. Chromatogr B. 2008, 875: 148-53. 10.1016/j.jchromb.2008.07.042.View ArticleGoogle Scholar
- Gujral RS, Haque SM, Kumar SA: A novel method for the determination of pregabalin in bulk pharmaceutical formulations and human urine samples. Afr J Pharm Pharmacol. 2009, 3: 327-334.Google Scholar
- Nirogi R, Kandikere V, Mudigonda K, Komarneni P, Aleti R: Liquid chromatography atmospheric pressure chemical ionization tandem mass spectrometry method for the quantification of pregabalin in human plasma. J Chromatogr B. 2009, 877: 3899-3906. 10.1016/j.jchromb.2009.10.004.View ArticleGoogle Scholar
- Oertel R, Arenz N, Pietsch J, Kirch W: Simultaneous determination of three anticonvulsants using hydrophilic interaction LC-MS. J Sep Sci. 2009, 32: 238-243. 10.1002/jssc.200800461.View ArticleGoogle Scholar
- Douša M, Gibala P, Lemr K: Liquid chromatographic separation of pregabalin and its possible impurities with fluorescence detection after postcolumn derivatization with o-phtaldialdehyde. J Pharm Biomed Anal. 2010, 53: 717-722. 10.1016/j.jpba.2010.04.008.View ArticleGoogle Scholar
- Kannapan N, Nayak SP, Venkatachalam T, Prabhakaran VJ: Analytical RP-HPLC Method for Development and Validation of Pregabalin and Methylcobalamine in Combined Capsule Formulation. Appl Chem Res. 2010, 13: 85-89.Google Scholar
- Kasawar GB, Farooqui MN: Development and validation of HPLC method for the determination of pregabalin in capsules. Indian J Pharm Sci. 2010, 72: 517-9. 10.4103/0250-474X.73935.View ArticleGoogle Scholar
- Martinc B, Grabnar I, Mrhar A, Vovk T: Rapid high-performance liquid chromatography method for determination of pregabalin in a pharmaceutical dosage form following derivatization with fluorescamine. J AOAC. 2010, 93: 1069-1076.Google Scholar
- Shah GR, Ghosh C, Thaker BTJ: Determination of pregabalin in human plasma by electrospray ionisation tandem mass spectroscopy. Adv Pharm Technol Res. 2010, 1: 354-357. 10.4103/0110-5558.72423.View ArticleGoogle Scholar
- Darwish IA: Kinetic spectrophotometric methods for determination of trimetazidine dihydrochloride. Anal Chim Acta. 2005, 551: 222-231. 10.1016/j.aca.2005.07.027.View ArticleGoogle Scholar
- Li Q, Zhang H: A novel spectrophotometric method for the determination of aminophylline in pharmaceutical samples in the presence of methanol. Anal Chim Acta. 2008, 551: 222-231.Google Scholar
- Mahmoud AM, Khalil NY, Darwish IA, Aboul-Fadl T: Selective Spectrophotometric and Spectrofluorometric Methods for the Determination of Amantadine Hydrochloride in Capsules and Plasma via Derivatization with 1,2-Naphthoquinone-4-sulphonate. Int J Anal Chem. 2009, 2009: 810104-Google Scholar
- Connor KA: Reaction Mechanisms in Organic Analytical Chemistry. 1973, Wiley: New York, U.S.A, 274-Google Scholar
- El-Enany N, El-Sherbiny D, Belal F: Spectrophotometric, spectrofluorometric and HPLC determination of desloratadine in dosage forms and human plasma. Chem Pharm Bull (Tokyo). 2007, 55: 1662-70. 10.1248/cpb.55.1662.View ArticleGoogle Scholar
- ICH Harmonized Tripartite Guideline: Validation of Analytical Procedures. Text and Methodology, Q2(R1), Current Step 4 Version, Parent Guidelines on Methodology. 2005, [http://www.bioforum.org.il/Uploads/Editor/karen/q2_r1_step4.pdf]Google Scholar
- Miller JN, Miller JC: Statistics and chemometrics for analytical chemistry. 2005, Prentice Hall: England, 256-5Google Scholar
- Rose J: Advanced physico-chemical experiments. 1964, Pitman: London, EnglandGoogle Scholar